Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.

Biotechnology

Health Care

Health Diagnostics

Life Sciences

Therapeutics

Oxford BioTherapeutics

Oxford BioTherapeutics' headquarters in Oxton, United Kingdom

Christian Rohlff

Andrew Dickinson

Bridget Biggar MAPP FCIPD

Harald Haeske

Ben Thomas

Ken Sayre

Tracy Coltman

Belinda Cairns

Bernd Seizinger

Jean-Pierre Bizzari

Jason Gould

The Research and Development team at Oxford BioTherapeutics is dedicated to advancing innovative therapies for cancer through rigorous scientific exploration and experimental validation. This team conducts cutting-edge research and development of biopharmaceuticals, focusing on antibody-drug conjugates and companion diagnostics, to ensure the efficacy and safety of next-generation cancer treatments. Collaborating across disciplines, they translate scientific findings into actionable insights that drive the company’s therapeutic pipeline forward.

Research and Development

The Leadership Team at Oxford BioTherapeutics guides the strategic vision and operational framework of the company, focusing on the development of innovative cancer therapies and companion diagnostics. Comprising key figures in executive management, finance, and operations, the team fosters collaboration across departments to drive external innovation, ensure effective resource allocation, and maintain alignment with the company’s overarching mission to improve patient outcomes.

Leadership Team

��

Oxford BioTherapeutics

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Offices

��������

Oxford BioTherapeutics

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Offices

Related companies

��